ALNYLAM PHARMACEUTICALS, INC. Annual Return On Equity in % from 2011 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Alnylam Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2011 to 2023.
  • Alnylam Pharmaceuticals, Inc. Return On Equity for the quarter ending June 30, 2024 was 47.9 %, a 89.9% decline year-over-year.
  • Alnylam Pharmaceuticals, Inc. annual Return On Equity for 2023 was 167 %.
  • Alnylam Pharmaceuticals, Inc. annual Return On Equity for 2022 was -1.29K %, a 1079% decline from 2021.
  • Alnylam Pharmaceuticals, Inc. annual Return On Equity for 2021 was -109 %, a 58.4% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 167 +1.45K Jan 1, 2023 Dec 31, 2023
2022 -1.29K -1.18K -1079% Jan 1, 2022 Dec 31, 2022
2021 -109 -40.3 -58.4% Jan 1, 2021 Dec 31, 2021
2020 -68.9 -13.1 -23.5% Jan 1, 2020 Dec 31, 2020
2019 -55.8 -6.34 -12.8% Jan 1, 2019 Dec 31, 2019
2018 -49.5 -8.4 -20.4% Jan 1, 2018 Dec 31, 2018
2017 -41.1 -2.24 -5.77% Jan 1, 2017 Dec 31, 2017
2016 -38.9 -17.7 -83.9% Jan 1, 2016 Dec 31, 2016
2015 -21.1 +17.4 +45.2% Jan 1, 2015 Dec 31, 2015
2014 -38.6 -8.51 -28.3% Jan 1, 2014 Dec 31, 2014
2013 -30.1 +30.8 +50.6% Jan 1, 2013 Dec 31, 2013
2012 -60.9 -17.2 -39.3% Jan 1, 2012 Dec 31, 2012
2011 -43.7 Jan 1, 2011 Dec 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.